1 Min Read
April 2 (Reuters) - Dr.Reddy’s Laboratories Ltd:
* CO, U.S. UNIT PROMIUS PHARMA ANNOUNCE FILING OF AN NDA FOR MIGRAINE CANDIDATE
* UPON APPROVAL, PRODUCT WILL BE COMMERCIALISED BY PROMIUS PHARMA Source text: bit.ly/2GOk7ib Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.